Press release
Clinical Trials Market is projected to grow at a CAGR of 6.8% during 2023-2031: Analysis by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Indication (Oncology, Infectious Di
It also covers key players and competitor analysis, providing a comprehensive understanding of the market's commercial landscape. The report is useful for gaining insights and understanding the market's outlook and prospects.
The global clinical trials market continues to thrive as a vital industry conducting research studies to assess the safety and effectiveness of drugs, medical devices, and other healthcare interventions. The market is being propelled by a variety of factors, including the rising prevalence of chronic diseases, increasing demand for personalized medicine, and ongoing development of innovative treatments and therapies. Additionally, the globalization of clinical trials presents opportunities for growth in emerging markets.
According to market research, the Global clinical trials market will reach $ 79,977.1 million by 2031, growing by 6.8% annually over 2021-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments.
๐๐๐ญ ๐ ๐ฌ๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ @:
https://www.pragmamarketresearch.com/reports/77065/global-clinical-trials-market-2021-2031-by-product-category-drugs-devices-procedures-phase-i-ii-iii-iv-design-interventional-observational-expanded-access-service-type-site-identification-lab-services-supply-logistic-decentralized-services-indication-oncology-infectious-diseases-cardiology-obesity-diabetes-neurology-end-user-and-region-trend-forecast-and-growth-opportunity/inquiry?UTM=AGPR
๐ฒ๐๐ ๐๐๐๐๐๐๐ ๐๐ ๐๐๐ ๐๐๐๐๐๐ ๐๐๐๐๐๐ ๐: Accell Clinical Research LLC, Charles River Laboratory, ClinDatrix Inc, Clinipace, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, ICON PLC, IQVIA Holdings Inc, Laboratory Corporation of America, Novo Nordisk AS, PAREXEL International Corporation, Pfizer Inc, Pharmaceutical Product Development LLC, PRA Health Sciences, Sanofi SA, SGS SA, Syneos Health Inc, Wuxi AppTec Inc, and others.
The report also includes the post COVID-19 impact, and Impact of Russia-Ukraine war on the market and a detailed analysis of the industry's end-user sectors.
The report offers an in-depth understanding of the Clinical Trials market and includes data from key players. It provides a detailed analysis of current trends and projected growth in the coming years, as well as information on drivers, opportunities, challenges, and threats. The report also provides comprehensive information on new products, developments, and future innovations in the market.
๐บ๐๐๐๐๐๐๐๐๐๐๐ ๐๐ ๐๐๐๐๐, ๐๐๐๐๐๐๐๐๐๐๐๐, ๐๐๐ ๐๐๐๐๐๐๐:
Based on Product Category, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Trials of Drugs
o Small Molecule Drugs
o Vaccines
o Cell & Gene Therapy
o Other Drugs
- Trials of Devices
- Trials of Procedures
Based on Phase, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Phase I
- Phase II
- Phase III
- Phase IV
๐๐ฎ๐ฒ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ (๐๐ข๐ง๐ ๐ฅ๐ ๐๐ฌ๐๐ซ) @
https://www.pragmamarketresearch.com/buy/77065?type=su&UTM=AGPR
By Service Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Protocol Designing
- Site Identification
- Patient Recruitment
- Laboratory Services
- Bioanalytical Testing Services
- Clinical Trial Data Management Services
- Clinical Trial Supply & Logistic Services
- Decentralized Clinical Trial Services
- Medical Device Testing Services
- Other Clinical Trial Services
By Indication, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
- Oncology
- Infectious Diseases
- Cardiology
- Obesity
- Diabetes
- Neurology
- Immunology
- Pain Management
- Other Indications
๐ป๐๐ ๐๐๐๐๐๐ ๐๐๐๐๐๐ ๐๐๐ ๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐:
The Middle East and Africa (GCC Countries and Egypt), North America (the United States, Mexico, and Canada), South America (Brazil, etc.), Europe (Turkey, Germany, Russia UK, Italy, France, etc.), and Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia).
๐ป๐๐ ๐๐๐๐๐๐'๐ ๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐ ๐๐๐:
To provide a comprehensive overview of the industry
To analyse the factors affecting the growth of the Clinical Trials market
To present past and future earnings of the market segments globally
To conduct a regional-level examination of the market and its current size and prospects
To study the market by product type and research methodologies
To profile key players in the market and assess their strengths and competitive structure.
To track the competitive advancements in the global Clinical Trials market.
๐๐๐ญ ๐ฆ๐จ๐ซ๐ ๐ข๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง ๐จ๐ง ๐ญ๐ก๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ, ๐ข๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ ๐๐๐, ๐๐๐๐ฅ๐ & ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ, ๐๐ฒ ๐ฏ๐ข๐ฌ๐ข๐ญ๐ข๐ง๐ :
https://www.pragmamarketresearch.com/reports/77065/global-clinical-trials-market-2021-2031-by-product-category-drugs-devices-procedures-phase-i-ii-iii-iv-design-interventional-observational-expanded-access-service-type-site-identification-lab-services-supply-logistic-decentralized-services-indication-oncology-infectious-diseases-cardiology-obesity-diabetes-neurology-end-user-and-region-trend-forecast-and-growth-opportunity?UTM=AGPR
Target Audience of the Global Clinical Trials Market in Market Study:
- Key Consulting Companies & Advisors
- Large, medium-sized, and small enterprises
- Venture capitalists
- Value-Added Resellers (VARs)
- Third-party knowledge providers
- Investment bankers
- Investors
The report is a valuable source of information for companies and individuals interested in the market and provides an in-depth knowledge of the market. The table of contents includes chapters on industry overview, global competition, production market analysis, sales, consumption, export, import by regions, market analysis by region, company profiles, market forecast, and conclusions.
๐๐จ๐ญ๐: Custom research report can be available upon request.
๐ฉ๐๐๐๐๐ ๐ ๐ซ๐๐๐ ๐ท๐๐๐๐๐๐ ๐๐๐๐ ๐ท๐ด๐น.
https://www.pragmamarketresearch.com/consulting-services
๐ด๐๐๐ ๐น๐๐๐๐๐๐ ๐๐ ๐ท๐๐๐๐๐ ๐ด๐๐๐๐๐ ๐น๐๐๐๐๐๐๐:
North America Clinical Trials Market 2023:
In 2021, North America was one of the leading regions for clinical trials, with a significant number of trials taking place in the United States and Canada. The region's strong pharmaceutical and biotech industries, well-established regulatory framework, and advanced healthcare infrastructure make it an attractive location for clinical trials.
https://www.pragmamarketresearch.com/reports/77066/north-america-clinical-trials-market-2021-2031-by-product-category-drugs-devices-procedures-phase-i-ii-iii-iv-design-interventional-observational-expanded-access-service-type-site-identification-lab-services-supply-logistic-decentralized-services-indication-oncology-infectious-diseases-cardiology-obesity-diabetes-neurology-end-user-and-country-trend-forecast-and-growth-opportunity?UTM=AGPR
Asia Pacific Clinical Trials Market 2023:
The Asia Pacific region has become an increasingly important location for clinical trials, with countries like China, India, and South Korea playing a significant role. The region's large population, diverse patient pool, and lower costs compared to developed countries have made it an attractive destination for clinical trials.
In recent years, there has been a trend towards increasing the number of clinical trials in the Asia Pacific region, driven by factors such as government initiatives to boost the healthcare industry, the rise of contract research organizations (CROs), and the growing demand for new therapies to address diseases prevalent in the region.
https://www.pragmamarketresearch.com/reports/77068/asia-pacific-clinical-trials-market-2021-2031-by-product-category-drugs-devices-procedures-phase-i-ii-iii-iv-design-interventional-observational-expanded-access-service-type-site-identification-lab-services-supply-logistic-decentralized-services-indication-oncology-infectious-diseases-cardiology-obesity-diabetes-neurology-end-user-and-country-trend-forecast-and-growth-opportunity?UTM=AGPR
Global and Regional Clinical Trial Support Service Market 2023:
The clinical trial support services market refers to a wide range of services that are used to support clinical trials, including site management, patient recruitment, data management, and regulatory affairs. This market has been growing in recent years due to the increasing complexity of clinical trials and the growing demand for specialized services.
https://www.pragmamarketresearch.com/reports/74076/global-clinical-trial-support-service-market?UTM=AGPR
Global and Regional Clinical Trial Supplies Market 2023:
The clinical trial supplies market refers to the products and services that are used in clinical trials, including drugs, medical devices, and ancillary supplies such as packaging and labeling materials. This market has been growing in recent years due to the increasing number and complexity of clinical trials, as well as the growing demand for specialized services.
https://www.pragmamarketresearch.com/reports/34696/2022-2027-Global-and-Regional-Clinical-Trial-Supplies-Industry-Status-and-Prospects-Professional-Market-Research-Report-Standard-Version?UTM=AGPR
Global Clinical Trial Supply And Logistics Market 2023:
The clinical trial supply and logistics market refers to the products and services used in the distribution, storage, and management of clinical trial supplies. This market has been growing in recent years due to the increasing number and complexity of clinical trials, as well as the growing demand for specialized services.
https://www.pragmamarketresearch.com/reports/118960/clinical-trial-supply-and-logistics-market?UTM=AGPR
Global and Regional Clinical Trial Supply and Logistic for Pharmaceutical Market 2023:
Factors driving growth in the clinical trial supply and logistics market for pharmaceuticals include the increasing number and complexity of clinical trials, the globalization of clinical trials, and the growing demand for specialized services such as temperature-controlled logistics and direct-to-patient delivery.
https://www.pragmamarketresearch.com/reports/95362/global-clinical-trial-supply-and-logistic-for-pharmaceutical-market?UTM=AGPR
Clinical Trial Imaging Market 2023:
Factors driving growth in the clinical trial imaging market include the increasing use of imaging technologies in clinical trials, the growing demand for personalized medicine, and the increasing complexity of clinical trial design. Additionally, the use of artificial intelligence and machine learning in imaging analysis is expected to create new opportunities in the market.
https://www.pragmamarketresearch.com/reports/81991/clinical-trial-imaging-market?UTM=AGPR
Global Biotechnology & Pharmaceutical Services Outsourcing Market 2023:
Factors driving growth in the biotechnology and pharmaceutical services outsourcing market include the increasing complexity and cost of drug development, the growing demand for personalized medicine, and the increasing outsourcing of services by large pharmaceutical companies. Additionally, the growth of the biotechnology sector is expected to create new opportunities in the market.
https://www.pragmamarketresearch.com/reports/77411/global-biotechnology-pharmaceutical-services-outsourcing-market?UTM=AGPR
Global Artificial Intelligence (AI) in Drug Discovery Market 2023:
Factors driving growth in the global AI in drug discovery market include the increasing demand for personalized medicine, the growing availability of large-scale data sets, and the increasing complexity of the drug discovery process. Additionally, the use of AI technologies in drug discovery is expected to lead to significant cost savings and reduced drug development times.
https://www.pragmamarketresearch.com/reports/76099/global-artificial-intelligence-ai-in-drug-discovery-market-2020-2026-by-offering-technology-drug-type-therapeutic-area-application-end-user-and-region-trend-forecast-and-growth-opportunity?UTM=AGPR
๐ช๐๐๐๐๐๐ ๐ผ๐:
๐๐ซ๐๐ ๐ฆ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก,
+1 425 230 0999
sales@pragmamarketresearch.com
๐จ๐๐๐๐ ๐ผ๐:
Pragma Market Research is a dynamic market research and consulting firm with experienced analysts in various industries. Our industries of expertise include Medical Devices, Pharmaceuticals, Semiconductors, Machinery, Information and Communication Technology, Automobiles, Chemicals and Materials, Packaging, Food and Beverages, Specialty Chemicals, Fast Moving Consumer Goods, and more.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Clinical Trials Market is projected to grow at a CAGR of 6.8% during 2023-2031: Analysis by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Indication (Oncology, Infectious Di here
News-ID: 2955175 • Views: โฆ
More Releases from Pragma Market Research and Business Consulting
๐๐ฅ๐จ๐๐๐ฅ ๐๐๐๐ข๐๐ซ๐ข๐ฅ๐ฅ๐๐ญ๐จ๐ซ ๐ โฆ
๐๐๐๐ข๐๐ซ๐ข๐ฅ๐ฅ๐๐ญ๐จ๐ซ ๐๐๐ซ๐ค๐๐ญ ๐๐ข๐ณ๐
The global Defibrillator market is experiencing consistent growth, driven by critical needs and technological advancements.
A new report by Pragma Market Research projects the market, valued at US$ 15.29 billion in 2024, to reach US$ 19.14 billion by 2031, growing at a CAGR of 3.3% during the forecast period.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ - https://www.pragmamarketresearch.com/reports/121527/defibrillator-market-size/inquiry?UTM=OPR25
๐๐๐ฒ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐๐ก๐๐ฉ๐ข๐ง๐ ๐ญ๐ก๐ ๐๐๐ซ๐ค๐๐ญ:
The Defibrillator market is a concentrated landscape, with keyโฆ
Transactional Banking Market Size, Growth and Opportunities from 2024 to 2030
๐ง๐ฟ๐ฎ๐ป๐๐ฎ๐ฐ๐๐ถ๐ผ๐ป๐ฎ๐น ๐๐ฎ๐ป๐ธ๐ถ๐ป๐ด ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฎ๐ฌ๐ฎ๐ฐ-๐ฎ๐ฌ๐ฏ๐ฌ
Transactional banking is a critical component of the global financial system, enabling the smooth execution of financial transactions for individuals, businesses, and governments.
This report explores the projected market trends, regional growth, major players, market segmentation by type and application, and the key drivers and opportunities shaping the future of transactional banking.
๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฆ๐ถ๐๐ฒ ๐ฎ๐ป๐ฑ ๐๐ฟ๐ผ๐๐๐ต
The global market for transactional banking was estimated to be worth US$ 215,228โฆ
Embedded Insurance Market Size, Driving Growth and Insights 2024-2030
๐๐บ๐ฏ๐ฒ๐ฑ๐ฑ๐ฒ๐ฑ ๐๐ป๐๐๐ฟ๐ฎ๐ป๐ฐ๐ฒ ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฎ๐ฌ๐ฎ๐ฐ-๐ฎ๐ฌ๐ฏ๐ฌ
The global Embedded Insurance market is on a path of robust growth, characterized by increasing integration of insurance products into consumer purchase journeys across various sectors.
This Report explores the projected market trends, regional growth, major players, market segmentation by type and application, and the key drivers and opportunities shaping the future of embedded insurance.
๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฆ๐ถ๐๐ฒ ๐ฎ๐ป๐ฑ ๐๐ฟ๐ผ๐๐๐ต
The global Embedded Insurance market was valued at $78,693.58 millionโฆ
Large Language Model (LLM) Market Size, Share Growth Drivers, Regional Insights, โฆ
๐๐ฎ๐ฟ๐ด๐ฒ ๐๐ฎ๐ป๐ด๐๐ฎ๐ด๐ฒ ๐ ๐ผ๐ฑ๐ฒ๐น (๐๐๐ ) ๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฎ๐ฌ๐ฎ๐ฐ
The global Large Language Model (LLM) market is poised for remarkable growth over the next several years. With applications spanning various industries and rapid advancements in AI technology, the market's expansion is driven by increasing demand for advanced language processing capabilities.
This report delves into the projected market trends, regional analysis, major players, market segmentation by type and application, growth drivers, and opportunities.
๐ ๐ฎ๐ฟ๐ธ๐ฒ๐ ๐ฆ๐ถ๐๐ฒ ๐ฎ๐ป๐ฑโฆ
More Releases for Trial
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems โฆ
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, withโฆ
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems โฆ
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, withโฆ
Clinical Trial Imaging market
The Clinical Trial Imaging market crossed the US$ 1.09 billion mark in 2022 and is expected to hit US$ 1.94 billion by 2030, recording a CAGR of 7.5% during the forecast period.
Rising R&D spending, a rapidly growing pharmaceutical industry, and an increase in the number of contract research organizations are some of the major factors driving the market's growth. There has been an increase in pharmaceutical companies due to theโฆ
Clinical Trial Management System
According to a new market report published by Persistence Market Research โGlobal Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019โ the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019.
Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
โฆ
Clinical Trial Logistics
Clinical Trial Logistics
16th to 17th May 2011, Marriott Regents Park, London, United Kingdom.
It currently costs just over ยฃ500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trialsโฆ
Clinical Trial Logistics
Announcing SMi's 5th annualโฆ
Clinical Trial Logistics conference
16th and 17th May 2011, Central London, UK
www.smi-online.co.uk/2011logistics-london6.asp
It currently costs just over ยฃ500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinicalโฆ
